Vaxcyte, Inc. (PCVX) Tops Q2 EPS by 5c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q2 EPS of ($0.70), $0.05 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
• Carvana (CVNA) PT Lowered to $85 at RBC Capital